HIV/AIDS
Investigators from University of California, U.S., zero in on HIV/AIDS
Published in AIDS Weekly, April 16th, 2007
Study 1: A new study, "Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation," is now available. "The killer cell Ig-like receptor (KIR) gene, KIR3DS1, has been implicated in slowing disease progression in HIV infection; however, little is known about its expression, function, or ligand specificity. Using retrovirally transduced NKL cells and peripheral blood NK cells from KIR3DS1-positive donors we assessed expression of this gene by flow cytometry and its...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-04-16)
More Articles from AIDS Weekly
- HIV/AIDS
Promising new drug studied for HIV - HIV/AIDS
RAND study finds religiosity can be an important tool in preventing the spread of HIV-AIDS - HIV/AIDS
Rush researchers participate in worldwide AIDS initiative led by Imperial College London - Vaccine Safety
Jefferson scientists find rabies-based vaccine could be effective against HIV - Cancer Vaccines
Bavarian Nordic A/S presents annual results 2006 - HIV/AIDS
AIDS Healthcare Foundation Sues California Over Delay on Medi-Cal for HIV-Infected - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
